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Objectives The authors sought to compare conservative and aggressive strategies for provisional
side branch (SB) intervention in coronary bifurcation lesions.
Background The optimal provisional approach for coronary bifurcation lesions has not been
established.
Methods In this prospective randomized trial, 258 patients with a coronary bifurcation lesion
treated with drug-eluting stents were randomized to a conservative (n  128) or aggressive (n 
130) SB intervention strategy. The criteria for SB intervention after main vessel stenting differed be-
tween the conservative and aggressive groups; Thrombolysis In Myocardial Infarction ﬂow grade 3
versus diameter stenosis 75% for non–left main bifurcations and diameter stenosis 75% versus
diameter stenosis 50% for left main bifurcations. The primary endpoint was target vessel failure
(cardiac death, myocardial infarction, or target vessel revascularization) at 12 months.
Results Left main bifurcation lesions were noted in 114 patients (44%) and true bifurcation lesions
in 171 patients (66%). SB ballooning after main vessel stenting and SB stenting after SB ballooning
were performed less frequently in the conservative group than in the aggressive group (25.8% vs.
68.5%, p  0.001; and 7.0% vs. 30.0%, p  0.001, respectively). The conservative strategy was asso-
ciated with a lower incidence of procedure-related myocardial necrosis compared with the aggres-
sive strategy (5.5% vs. 17.7%, p  0.002). At 12 months, the incidence of target vessel failure was
similar in both groups (9.4% in the conservative group vs. 9.2% in the aggressive group, p  0.97).
Conclusions Compared with the aggressive strategy, the conservative strategy for provisional SB
intervention was associated with similar long-term clinical outcomes and a lower incidence of proce-
dure-related myocardial necrosis. (Optimal Strategy for Side Branch Stenting in Coronary Bifurcation
Lesions [SMART-STRATEGY]; NCT00794014) (J Am Coll Cardiol Intv 2012;5:1133–40) © 2012 by the
American College of Cardiology Foundation
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1134Some randomized trials have reported that the elective
2-stent technique is not superior to the provisional approach
for coronary bifurcation lesions (1–3). As a result, selective
side branch (SB) intervention after main vessel (MV)
stenting is now regarded as the standard strategy for most
bifurcation lesions (4,5). However, the optimal indications
for SB ballooning or stenting during the provisional ap-
proach have not been established. Although previous studies
reported that routine kissing ballooning after MV stenting
did not improve clinical outcomes in the 1-stent technique
(6,7), these studies still did not answer when the SB
intervention should or should not be performed. Moreover,
left main (LM) bifurcation lesions were not included in any
previous studies. Therefore, to determine the optimal indi-
cations for SB ballooning and/or stenting in the provisional
approach, we compared conservative and aggressive strate-
gies in patients undergoing percutaneous coronary interven-
tion (PCI) with drug-eluting
stents (DES) for non-LM bifur-
cations and LM bifurcations.
Methods
Study design and patients. The
present study was a prospective,
randomized, open-label, single-
center study designed to com-
pare conservative versus aggres-
sive strategies for provisional SB
intervention during coronary bi-
furcation PCI with DES. The
local institutional review board
approved this study, and all sub-
jects gave their informed consent
for participation. Patients with
stable coronary artery disease or
non–ST-segment elevation acute
coronary syndrome were considered eligible for enrollment.
The inclusion criteria were an elective coronary intervention
for a de novo coronary bifurcation lesion, including unpro-
tected LM, and MV diameter 2.5 mm and SB diameter
2.3 mm by visual estimation. We excluded patients with
hemodynamic instability, left ventricular ejection fraction
25%, and those undergoing primary PCI.
Study procedures and follow-up. All patients received dual
ral antiplatelet therapy with 300-mg aspirin and either
00- or 600-mg clopidogrel before PCI if they had not
reviously received these drugs. Intravenous heparin was
dministered to maintain an activated clotting time 300 s.
ntravenous administration of glycoprotein IIb/IIIa receptor
ntagonists was used at the operator’s discretion. The
election of DES was also left to the operator’s discretion,
ut the same type of DES was implanted in both branches.
Abbreviations
and Acronyms
DES  drug-eluting stent(s)
LM  left main
MI  myocardial infarction
MV  main vessel
PCI  percutaneous
coronary intervention
SB  side branch
TBR  target bifurcation
revascularization
TIMI  Thrombolysis In
Myocardial Infarction
TLR  target lesion
revascularization
TVF  target vessel failure
TVR  target vessel
revascularizationhe myocardial band fraction of creatine kinase-MB (CK-B) was measured at 6 h, and 18 to 24 h post PCI, and at
ischarge.
Patients were randomly assigned to undergo the conser-
ative or the aggressive treatment strategy for provisional SB
ntervention (Fig. 1). Randomization was performed after
V stenting using a computer-based 1:1 randomization
cheme, and patients were stratified by the presence or
bsence of LM bifurcation lesion. The triggers for SB
allooning and stenting happened only if the criteria were
et. If the criteria were not met, no further intervention was
erformed. If SB ballooning after MV stenting was needed,
issing balloon inflation was mandatory. If SB stenting was
ndicated, the T-stenting and small protrusion technique, in
hich the SB stent was pulled back slightly into the MV to
ully cover the ostium of the SB, was exclusively used (8).
inal kissing balloon inflation was mandatory after SB
tenting. All procedures were performed under intravascular
ltrasound guidance whenever possible.
LEFT MAIN BIFURCATION LESION. In the conservative
roup, SB ballooning followed by kissing ballooning was
erformed only if there was diameter stenosis 75% in the
B after MV stenting. SB stenting was performed only if
here was diameter stenosis 50% or Type B or greater
issection in the SB after ballooning. In the aggressive
roup, SB ballooning followed by kissing ballooning was
erformed only if there was diameter stenosis 50% in the
B after MV stenting. SB stenting was performed only if
here was diameter stenosis 30% or Type B or greater
issection in the SB after ballooning.
NON–LEFT MAIN BIFURCATION LESION. In the conservative
roup, SB ballooning followed by kissing ballooning was
erformed only if there was Thrombolysis In Myocardial
nfarction (TIMI) flow grade 3 in the SB after MV
tenting. SB stenting was performed only if there was TIMI
ow grade 3 in the SB after ballooning. In the aggressive
roup, SB ballooning followed by kissing ballooning was
erformed only if there was diameter stenosis 75% in
the SB after MV stenting. SB stenting was performed
only if there was diameter stenosis 50% in the SB after
ballooning.
Follow-up. Clinical follow-up was performed with office
visits or telephone contacts at 1, 3, 9, and 12 months after
intervention. Adverse events were monitored throughout
the study period. Follow-up coronary angiography and
intravascular ultrasound were performed at 9 months unless
clinically indicated earlier.
Study endpoints and deﬁnitions. The primary endpoint
was the occurrence of target vessel failure (TVF), defined
as a composite of cardiac death, spontaneous myocardial
infarction (MI), or target vessel revascularization (TVR)
during the 12-month period after randomization. Secondary
endpoints included the individual components of the pri-
mary endpoint, target lesion revascularization (TLR), and
target bifurcation revascularization (TBR) at 12 months;
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1135procedure-related myocardial necrosis; and binary angio-
graphic (re)stenosis in the MV and SB as measured by
quantitative coronary analysis at 9 months.
All deaths were considered cardiac in origin unless a
definite noncardiac cause could be established. Spontaneous
MI was defined as elevated cardiac enzymes (CK-MB or
troponin I) above the upper limit of the normal range with
ischemic symptoms or electrocardiography findings indica-
tive of ischemia not related to the index procedure (6). TVR
Figure 1. Trial Profile
Patients were randomized 1:1 to conservative or aggressive strategy for provis
cation lesion. (B) Non–left main bifurcation lesion. TAP  T-stenting and smalwas defined as repeat revascularization of the target vessel by lPCI or bypass graft surgery. TLR was defined as repeat
revascularization of the lesion within 5 mm of stent deploy-
ment or bypass graft surgery in the target vessel. TBR was
defined as repeat revascularization with stenosis 50%
ithin 5 mm proximal or distal to the carina of bifurcation,
nto the MV and/or SB (9). Procedure-related myocardial
ecrosis was defined as a rise in CK-MB 3 times the
pper normal limit within the first 48 h after the index
rocedure. In patients with elevated baseline cardiac enzyme
side branch (SB) intervention after main vessel stenting. (A) Left main bifur-
usion; TIMI  Thrombolysis In Myocardial Infarction.ionalevels, procedure-related myocardial necrosis was defined as
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1136a subsequent increase 2-fold from the baseline value (10).
Stent thrombosis was assessed based on the definitions of
the Academic Research Consortium as definite, probable, or
possible stent thrombosis (11).
Quantitative coronary angiographic analysis. All baseline,
procedural, and follow-up coronary angiographies were
analyzed by an independent blinded observer using an
automated edge-detection system (Centricity CA1000, GE,
Waukesha, Wisconsin). The minimum luminal diameter
and reference diameter before, immediately after the proce-
dure, and at follow-up were measured in matched views.
Binary angiographic (re)stenosis was defined as a lumen
diameter stenosis of 50% at any of the following sites:
1) inside the stent; 2) within 5 mm proximal or distal to the
stent; 3) within the proximal 5 mm (SB ostium) of the
un-intervened SB; or 4) at the site of balloon inflation in the
SB. Late lumen loss was defined as the difference between
minimum luminal diameter immediately after the procedure
and at 9 months. Bifurcation lesions were classified accord-
ing to the Medina classification, in which the proximal MV,
distal MV, and SB components of the bifurcation are each
assigned a score of 1 or 0 depending on the presence or
absence of 50% stenosis (12). Medina classification type
(1.1.1), (1.0.1), and (0.1.1) lesions were defined as true
bifurcation lesions.
Statistical analysis. Power calculations were based on an
xpected 12-month TVF rate of 24% in the conservative
roup. With an alpha of 5% and power of 80%, 112 patients
Table 1. Baseline Characteristics
Conservative
(n  128)
Aggressive
(n  130) p Value
Age, yrs 61.8 10.1 61.5 10.2 0.83
Male 105 (82.0) 108 (83.1) 0.83
Clinical presentation 0.51
Silent ischemia 13 (10.2) 7 (5.4)
Stable angina 80 (62.5) 82 (63.1)
Unstable angina 26 (20.3) 31 (23.8)
Myocardial infarction 9 (7.0) 10 (7.7)
Hypertension 70 (54.7) 75 (57.7) 0.63
Diabetes mellitus 37 (28.9) 33 (25.4) 0.53
Dyslipidemia 16 (12.5) 17 (13.1) 0.89
Current smoker 33 (25.8) 23 (17.7) 0.12
Family history of coronary artery
disease
17 (13.3) 19 (14.6) 0.76
Cerebrovascular accident 5 (3.9) 10 (7.7) 0.19
Chronic renal failure 2 (1.6) 4 (3.1) 0.68
Previous myocardial infarction 7 (5.5) 5 (3.8) 0.54
Previous percutaneous coronary
intervention
14 (10.9) 9 (6.9) 0.26
Previous coronary bypass graft surgery 0 1 (0.8) 0.99
Left ventricular ejection fraction, % 60.5 7.3 59.3 10.7 0.41
Values are mean SD or n (%).ould be needed in each group to detect up to a 14%eduction (about 60% relative reduction) in 12-month TVF
ate. Assuming a 10% loss to follow-up loss, 250 patients
ould be needed for both groups.
Continuous variables were expressed as the mean  SD
r the median and interquartile range and were compared
sing an independent t test or the Wilcoxon rank sum test.
ategorical variables were compared with Pearson chi-
quare or Fisher exact tests. A p value 0.05 in the 2-tailed
est was considered significant. The Statistical Analysis
oftware package (SAS version 9.1, SAS Institute, Cary,
orth Carolina) was used for all analyses.
esults
Baseline clinical characteristics. Between July 2007 and De-
ember 2010, a total of 258 patients with bifurcation lesions
Table 2. Procedural Characteristics
Conservative
(n  128)
Aggressive
(n  130) p Value
Target vessel 0.91
Left main bifurcation 57 (44.5) 57 (43.8)
Non–left main bifurcation 71 (55.5) 73 (56.2)
LAD/diagonal 52 (40.6) 66 (50.8)
LCX/OM 10 (7.8) 3 (2.3)
RCA bifurcation 9 (7.0) 4 (3.1)
Medina classiﬁcation 0.74
True bifurcation 82 (64.1) 89 (68.5) 0.46
1.1.1 68 (53.1) 76 (58.5)
1.0.1 8 (6.3) 4 (3.1)
0.1.1 6 (4.7) 9 (6.9)
Non-true bifurcation 46 (35.9) 41 (31.5) 0.46
1.0.0 2 (1.6) 2 (1.5)
0.1.0 26 (20.3) 19 (14.6)
1.1.0 17 (13.3) 19 (14.6)
0.0.1 1 (0.8) 1 (0.8)
Remote site intervention 39 (30.5) 35 (26.9) 0.53
Treatment according to randomization 128 (100) 129 (99.2) 0.99
Type of stent used 0.57
Sirolimus-eluting stent 60 (46.9) 62 (47.7)
Everolimus-eluting stent 40 (31.3) 35 (26.9)
Other drug-eluting stents 28 (21.9) 33 (25.4)
Main vessel
No. of stents per lesion 1.2 0.4 1.2 0.4 0.41
Total stent length, mm 24.9 5.6 25.1 5.3 0.76
Maximal stent diameter, mm 3.3 0.4 3.3 0.4 0.45
Maximal balloon pressure, atm 15.1 3.4 14.7 3.1 0.24
Side branch (n  48) n  9 n  39
No. of stents per lesion 1.0 0.0 1.0 0.2 0.64
Total stent length, mm 18.4 7.8 17.7 5.6 0.73
Maximal stent diameter, mm 2.8 0.2 2.9 0.4 0.46
Maximal balloon pressure, atm 14.3 3.0 15.7 2.6 0.17
Values are n (%) or mean SD.
LAD  left anterior descending artery; LCX  left circumflex artery; OM  obtuse marginalcoronary artery; RCA right coronary artery.
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1137were enrolled and randomly assigned to either the conser-
vative (n 128) or the aggressive group (n 130). Baseline
clinical characteristics were well matched between the 2
groups (Table 1).
Angiographic and procedural characteristics. There were no
significant differences in the angiographic and procedural
characteristics between the 2 groups (Table 2). An LM
bifurcation lesion was noted in 114 patients (44%), and a
true bifurcation lesion was detected in 171 patients (66%).
No difference was found between the 2 groups in the
distribution of true and non-true bifurcations based on the
Medina classification (p  0.74). Sirolimus-eluting and
verolimus-eluting stents were used predominantly, with no
ifference between the study groups (p  0.57). The
umber of stents, total stent length, and stent diameter
mplanted in the MV and SB, and the rate of treatment
ccording to randomization were similar in the 2 groups.
igure 2 shows the rates of SB ballooning and stenting after
tent implantation of the MV. SB balloon dilation after MV
tenting was more frequently performed in the aggressive
roup than in the conservative group (68.5% vs. 25.8%, p 
.001). SB stenting after SB dilation and kissing ballooning
as also more frequently required in the aggressive group
han in the conservative group (30.0% vs. 7.0%, p  0.001).
nly 1 patient randomized to the aggressive strategy failed
o receive the assigned treatment due to rewiring failure.
Clinical outcomes. The aggressive strategy was associated
ith a significantly higher incidence of procedure-related
yocardial necrosis compared with the conservative strategy
Figure 2. The Rates of SB Ballooning and Stenting
(A) Side branch (SB) ballooning after main vessel stenting according to treatm
strategies. LM  left main.17.7% vs. 5.5%, p  0.002). Clinical follow-up data at 12
onths were available in all patients (Table 3). The cumu-
ative incidence of TVF was similar in the 2 groups (9.2% in
he aggressive group vs. 9.4% in the conservative group, p
.97) (Fig. 3). Similarly, both groups had comparable
ncidences of individual endpoints of cardiac death, spon-
aneous MI, TVR, and TLR. No significant difference was
ound in the rate of TBR between the groups (3.1% in the
ggressive group vs. 4.7% in the conservative group, p 
.50). Only 1 patient died of probable stent thrombosis
uring the follow-up period; this was a patient in the
rategies. (B) SB stenting after side branch ballooning according to treatment
Table 3. Clinical Outcomes at 12-Month Follow-Up
Conservative
(n  128)
Aggressive
(n  130) p Value
Total death 1 (0.8) 3 (2.3) 0.62
Cardiac death 0 1 (0.8) 0.99
Stent thrombosis 0 1 (0.8) 0.99
Spontaneous myocardial infarction 0 0 —
Procedure-related myocardial necrosis 7 (5.5) 23 (17.7) 0.002
Target bifurcation revascularization 6 (4.7) 4 (3.1) 0.50
Target lesion revascularization 10 (7.8) 7 (5.4) 0.43
Target lesion revascularization for MV 5 (3.9) 4 (3.1) 0.75
Target lesion revascularization for SB 5 (3.9) 4 (3.1) 0.98
Target vessel revascularization 12 (9.4) 11 (8.5) 0.80
Target vessel failure* 12 (9.4) 12 (9.2) 0.97
Values are n (%). *Defined as a composite of cardiac death, spontaneousmyocardial infarction, or
target vessel revascularization.
MVmain vessel; SB side branch.ent st
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1138aggressive group who underwent stenting of both branches
for a LM bifurcation lesion.
Quantitative coronary angiography analysis. Angiographic
follow-up at 9 months was performed in 218 (84.5%)
patients, 104 of whom were randomized to the conservative
strategy and 114 to the aggressive strategy. Baseline quan-
titative coronary angiographic characteristics were well
matched between the 2 groups (Table 4). There were
significant differences in the SB between the 2 treatment
strategies, with smaller minimal luminal diameters and
increased diameter stenosis after the index procedure and at
follow-up in the conservative group. The acute gain in the
SB was significantly greater in the aggressive group than in
the conservative group. Late lumen loss in the MV was not
significantly different between the 2 groups, but that of the
SB tended to be greater in the aggressive group. At
follow-up, the binary restenosis rate of the MV was similar
between the groups, but (re)stenosis of the SB was signifi-
cantly higher in the conservative group than in the aggres-
sive group (p  0.04).
LM and non-LM bifurcation subgroup analysis. In patients
ith LM bifurcation lesions (114 patients, 44%), the 12-
onth TVF rates were 10.5% and 10.5% (p 0.99) and the
LR rates were 5.3% and 8.8% (p 0.46) for the aggressive
nd conservative groups, respectively (Online Table 1). The
onservative group had smaller minimal luminal diameters
nd increased diameter stenosis in the SB after the index
rocedure and at follow-up (Online Table 2). The binary
re)stenosis rates of the MV and SB on the 9-month
ollow-up angiogram were similar between the groups
Online Table 2). In patients with non-LM bifurcation
esions (144 patients, 56%), the 12-month TVF rates were
.2% and 8.5% (p 0.99) and the TLR rates were 5.5% and
.0% (p  0.74) in the aggressive and conservative groups,
Figure 3. Clinical Outcomes
Kaplan-Meier curves up to 12 months are shown for the composite out-
come of cardiac death, myocardial infarction, and target vessel revascular-
ization in the conservative versus aggressive group.respectively (Online Table 3). At follow-up, the binaryrestenosis rate of the MV was similar between the groups
(6.1% vs. 5.6%, p  0.99), but (re)stenosis of the SB was
significantly lower in the aggressive group than in the
conservative group (18.2% vs. 42.6%, p  0.003) (Online
Table 4).
Discussion
This study is the first to our knowledge to compare different
strategies for provisional SB intervention in patients under-
going coronary bifurcation PCI. The main findings of this
study are as follows: 1) the conservative strategy for provi-
sional SB ballooning or stenting yielded long-term clinical
outcomes similar to those of the aggressive strategy; 2) the
conservative strategy was associated with a lower incidence
of procedure-related myocardial necrosis; 3) a provisional
SB approach for LM bifurcation lesions was feasible and
effective; and 4) the 9-month angiographic (re)stenosis rate
Table 4. Quantitative Coronary Angiographic Analysis
Conservative
(n  128)
Aggressive
(n  130) p Value
Bifurcation angle 64.7 24.3 63.5 22.7 0.68
Pre-intervention
MV RD, mm 3.01 0.45 3.07 0.58 0.37
SB RD, mm 2.46 0.55 2.49 0.54 0.64
mm. 0.77 0.48 0.82 0.47 0.43
SB MLD, mm 1.29 0.69 1.27 0.71 0.83
MV DS,% 74.6 15.2 73.4 14.6 0.55
SB DS, % 48.8 21.9 50.0 22.9 0.66
MV lesion length, mm 13.2 6.9 13.7 8.1 0.66
SB lesion length, mm 4.4 4.5 4.9 4.0 0.40
Post-intervention
MV RD, mm 3.20 0.46 3.24 0.60 0.51
SB RD, mm 2.44 0.52 2.47 0.53 0.61
MV MLD, mm 2.54 0.41 2.58 0.43 0.45
SB MLD, mm 1.48 0.66 1.77 0.64 0.001
MV DS, % 20.5 5.8 20.8 6.1 0.70
SB DS, % 40.7 20.3 29.3 18.9 0.001
MV acute gain, mm 1.77 0.47 1.76 0.50 0.91
SB acute gain, mm 0.19 0.62 0.49 0.67 0.001
Follow-up at 9 months n  104 n  114
MV RD, mm 3.17 0.45 3.21 0.53 0.50
SB RD, mm 2.39 0.50 2.48 0.54 0.21
MV MLD, mm 2.28 0.54 2.27 0.51 0.92
SB MLD, mm 1.34 0.58 1.57 0.57 0.004
MV late lumen loss, mm 0.27 0.30 0.29 0.36 0.69
SB late lumen loss, mm 0.13 0.36 0.23 0.44 0.08
MV DS, % 28.2 12.2 29.4 10.5 0.46
SB DS, % 45.0 18.9 37.0 16.3 0.001
MV restenosis 5 (4.8) 6 (5.3) 0.88
SB restenosis 27 (26.0) 17 (14.9) 0.04
Values are mean SD or n (%).
DS diameter stenosis; MLDminimum luminal diameter; RD reference diameter; otherabbreviations as in Table 3.
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1139was similar between the 2 groups for the MV, but was
significantly higher in the conservative group for the SB.
Although the 1-stent technique with provisional SB
intervention is simple and is now regarded as the standard
technique for most bifurcation lesions (1,3,13), SB balloon-
ing or stenting is still required in a substantial portion of
patients. However, the appropriate criteria for SB balloon-
ing or stenting have not been established. In previous
studies, the rate of crossover to SB stenting during provi-
sional SB intervention was highly variable, mainly due to
different criteria for the SB stenting. Several randomized
studies, including the CACTUS (Coronary Bifurcations:
Application of the Crushing Technique Using Sirolimus-
Eluting Stents) study, in which residual stenosis 50% was
considered 1 of the criteria for SB stenting, found that
approximately one-third of patients in the provisional group
crossed over to the 2-stent group (2,14). This crossover rate
was similar to that of the aggressive strategy (30%) in the
present study. By contrast, the Nordic Bifurcation Study
and BBC ONE (British Bifurcation Coronary Study: Old,
New, and Evolving Strategies) used very strict criteria for
SB stenting, such as impaired flow or severe residual
stenosis (1,3,15). In those studies, the crossover rate to the
2-stent technique was only 2% to 4%; this is slightly lower
than that of the conservative strategy (7%) in the present
study, partly because we included LM bifurcation.
To date, there has been no study comparing aggressive
and conservative strategies of provisional SB intervention
after MV stenting. The present study found that the
aggressive strategy for SB ballooning or stenting did not
provide better clinical outcomes than the conservative strat-
egy. There was no significant difference between the 2
treatment groups in the binary restenosis rate of the MV at
the 9-month angiographic follow-up. Although the rate of
SB (re)stenosis was higher in the conservative group, this
did not translate into increased clinically driven revascular-
ization rates.
The feasibility and usefulness of a provisional approach in
patients with LM bifurcation lesions have not been fully
assessed in previous trials comparing provisional SB stenting
to a systematic 2-stent approach because these studies
excluded LM bifurcation lesions or included a limited
number of cases (2,3,13,14). By contrast, the present study
included a substantial number of cases with LM bifurcation
lesions. Although the approach to keep SB just patent seems
reasonable in the treatment of non-LM bifurcation or a
relatively small branch from previous reports and ours (16),
this approach might be limited in a large SB with a large
amount of subtended myocardium, such as a LM bifurca-
tion. Therefore, we adopted different criteria for provisional
SB intervention according to the involvement of LM
bifurcation. In the treatment of LM bifurcation lesions, the
criterion of conservative strategy for the initiation of SB
intervention was diameter stenosis 75% in SB after MVstenting. This criterion was based on a previous report that
the vast majority of lesions with SB stenosis 75% after
MV stenting are not associated with ischemia, and thus do
not need further treatment (17). When applying this crite-
rion, we showed that LM bifurcation lesions can be treated
safely and effectively by a provisional SB approach. Al-
though both strategies for provisional SB ballooning or
stenting provided favorable and comparable clinical out-
comes in the treatment of LM bifurcation lesions, there was
a higher incidence of procedure-related myocardial necrosis
in patients who underwent the aggressive strategy than in
those who underwent the conservative one. In addition,
patients treated with the aggressive strategy were 3 times
more likely to need SB stenting than the conservative group.
Previous studies showed that, compared with the 2-stent
technique, use of the 1-stent technique for the treatment of
LM bifurcation lesions with DES was associated with a
significant reduction in major adverse cardiac events
(18,19). Considering the significance of periprocedural
myocardial necrosis together with this finding, the conser-
vative strategy could initially be considered as the preferred
approach for the treatment of LM bifurcation lesions. It is
also conceivable that the conservative strategy would be
simpler and more cost effective, and could be performed
with less contrast and a shorter procedural time.
Study limitations. First, the sample size was relatively small.
Although we calculated the sample size based on previous
data, the clinical event rate in the conservative group was
lower than expected. With an event rate of 9% in the
conservative group, the power was only about 42%. In
addition, different properties of the LM and non-LM lesion
subsets were not considered in the sample size calculation.
Second, the present study was an inevitably open design,
and both patients and operators were aware of the strategy
used, which might have introduced bias in the assessment of
symptoms at follow-up. No specific functional testing was
systematically performed during the follow-up period.
Conclusions
In patients undergoing coronary bifurcation stenting with
the provisional approach, the conservative strategy for pro-
visional SB intervention was associated with similar clinical
outcomes and a lower incidence of procedure-related myo-
cardial necrosis compared with the aggressive strategy.
However, these are hypothesis-generating findings due to
the small sample size, and warrant a large randomized study.
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